New York Cardiovascular Symposium
December 11 − 13, 2015
New York Hilton Midtown
New York City

Course Director(s): Valentin Fuster, MD, PhD, MACC

Conflict of Interest (COI) Policy / Disclosures

ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.


Friday, December 11

Coronary Artery Disease -- Challenges in 2015
Session I: New Discoveries in Athero-thrombogenesis and Technologies
Dr. Bhatt, Presiding

7:30 a.m. Noninvasive Evaluation of Subclinical Atherosclerotic Disease Burden
A Powerful Prognostic Tool Implicating Heart, Brain and Aging
Dr. Fuster
Download PDF
Watch Presentation
8:00 a.m. Invasive Evaluation of High Risk or Vulnerable Plaque
A Powerful Therapeutic Tool to Address Potential Pharmacological Agents
Dr. Narula
Download PDF
8:25 a.m. The Role of the Various Monocyte Types in Athero-thrombotic Disease
Protective vs. Detrimental Effects and Therapeutic Implications
Dr. Nahrendorf
Download PDF
8:50 p.m. Panel Discussion
Drs. Fuster, Nahrendorf and Narula